STOPFOP: A European phase II clinical trial using saracatinib to treat FOP

• Bernard J. Smilde,
• Richard Keen,
• Clemens Stockklausner,
• Dong Liu,
• Alex Bullock,
• Anette von Delft,
• Natasja M. van Schoor,
• Paul B. Yu,
• E. Marelise W. Eekhoff

Affiliations

Bernard J. Smilde

Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands; Corresponding author.

Richard Keen

Department of Rheumatology, Royal National Orthopaedic Hospital, London, United Kingdom

Clemens Stockklausner

Department of Paediatrics, Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany

Dong Liu

Research and Development, AstraZeneca, Boston, United States,

Alex Bullock

Nuffield Department of Medicine, University of Oxford, Oxform, United Kingdom

Anette von Delft

Nuffield Department of Medicine, University of Oxford, Oxform, United Kingdom

Natasja M. van Schoor

Department of Epidemiology and Biostatistics, Amsterdam University Medical Center, Amsterdam, Netherlands

Paul B. Yu

Department of Medicine, Brigham and Women's Hospital, Boston, United States

E. Marelise W. Eekhoff

Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands